COMPANY PROFILE

Aviv Scientific

Explore full profile

Personalized protocols enhancing brain and body performance during aging with clinically proven programs

Bnei Brak, IsraelFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Aviv Scientific

Aviv Clinics specializes in enhancing cognitive and physical performance in aging individuals through personalized medical programs. The company operates in the healthcare sector, focusing on age-related cognitive and functional decline. Aviv Clinics serves clients who are looking to maintain or improve their mental and physical health as they age. The business model revolves around offering a highly effective, personalized protocol known as the Aviv Medical Program, which includes the use of hyperbaric medicine. This program is designed to reset, retain, and restore youthful vitality, thereby improving the quality of life and extending the healthspan of its clients. Aviv Clinics generates revenue through the provision of these specialized medical services, which are tailored to meet the unique needs of each client. The company aims to expand its network of clinics to reach a broader audience and help more people live healthier, longer lives.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Bnei Brak, Israel
Employees: 19
Open positions: None listed
Dealroom signal: 65.9/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Tech for Patients, Biotech and Pharma, Longevity, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Sep 2021	$40M	$160M	Danel Group · Deep Insight	—
SEEDOther financing	Jul 2019	$12M	$48M	Undisclosed	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Aviv Scientific website traffic

Latest recorded traffic for Aviv Scientific is 25K monthly website visits, up 38.9% over the last three months. Aviv Scientific's team declined 17.4% over the past year.

Latest monthly visits25K 3-month web change+38.9% 1-year team growth-17.4%

Monthly website visitsJan 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBIOMILQLeverages breakthrough mammary biotechnology platform to produce human milk and other products for human health	Durham, United States	Operational	3	$25M	$84M
IKIkarovecBi-functional gene therapies for chronic eye diseases	Norwich, United Kingdom	Operational
NTNightStar TherapeuticsAAV gene therapies for inherited retinal diseases	London, United Kingdom	Acquired
GTGyroscope TherapeuticsDeveloping one-time gene therapies for retinal diseases	London, United Kingdom	Acquired
VHVirta HealthDelivers treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery	Denver, United States	Operational
AKAkiliDelivering the first-and-only prescription treatment delivered through a video game	Boston, United States	Acquired
HEHelixThe leading population genomics company working at the intersection of clinical care, research, and genomics	San Mateo, United States	Operational
ATAutifony TherapeuticsNovel medicines targeting ion channels for CNS disorders	Stevenage, United Kingdom	Operational